| Literature DB >> 16323318 |
Suparna Das Choudhuri1, Sloan Ayers, William H Soine, Kevin A Reynolds.
Abstract
Phoslactomycin B (PLM-B), a potent and selective inhibitor of serine threonine phosphatase is of interest for its antitumor, antifungal and antiviral activity. Described herein is an evaluation of the solution stability of phoslactomycin B at various pH and temperature conditions. Phoslactomycin B was produced from a NPI mutant strain of Streptomyces sp. HK-803 and purified by semi-preparative HPLC. A study of PLM-B degradation was carried out in the pH range of 2 approximately 10 at 30 degrees C and 50 degrees C using an HPLC assay. The PLM-B decomposition was observed to exhibit a U-shaped pH profile and demonstrated both acid and base-catalyzed decomposition. The decomposition could be described by the equation kOBS=kH x 10(-PH) + kOH x 10(pH-14) (kH=45 +/- 7 M(-1) h (-1); kOH= 448+/-73 M(-1h)(-1). PLM-B was found to be most stable at pH 6.63. The major acid and base products were separated and purified. Mass spectroscopic and NMR analysis revealed hydrolysis of the alpha, beta-unsaturated lactone provided the major degradation product under base conditions. Two other products in which hydration of the alpha, beta-unsaturated double bond preceded hydrolysis or methanolysis of the lactone were obtained. Under acidic condition MS and NMR analysis revealed that a dehydration step provided a C9-C11 phosphorinane derivative of PLM-B as one of the major products. The remaining acid degradation products were shown to be mixture of various dehydration products containing an additional double bond in central core of the PLM-B carbon skeleton. The major acid and base degradation products had dramatically reduced antifungal activity despite retaining the same structural core.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16323318 DOI: 10.1038/ja.2005.78
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN: 0021-8820 Impact factor: 2.649